Skip to main content
. 2009 Apr;67(4):421–426. doi: 10.1111/j.1365-2125.2009.03370.x

Table 3.

Effect of carbamazepine (CBZ) on lapatinib (LAP) pharmacokinetics

Parameter LAP alone* (n= 24) LAP + CBZ* (n= 23) Comparison (n= 23)
AUC, h ng−1 ml−1 3526 (2888, 4306) 984 (826, 1171) 0.28 (0.23, 0.32)
Cmax, ng ml−1 261 (209, 327) 110 (90.5, 134) 0.41 (0.34, 0.51)
tmax, h 4.0 (2.5, 6.0) 3.0 (1.0, 8.0) −0.21 (−0.70, 0.76)
tlag, h 0.12 (0.00, 0.50) 0.25 (0.00, 1.00) 0.00 (0.00, 0.14)
ka, h−1 0.70 (0.59, 0.82) 0.50 (0.39, 0.63) 0.72 (0.54, 0.96)
t1/2, h 10.2 (9.24, 11.3) 9.98 (8.12, 12.3) 0.98 (0.80, 1.19)
*

Geometric mean (95% CI) for AUC, Cmax, ka, t1/2; median (range) for tlag and tmax.

Geometric least-squares mean ratio (95% CI) for AUC, Cmax, ka, t1/2; median difference for tmax and tlag.